1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Primary Central Nervous System Neoplasm: new trials by email Literature Review of Primary Central Nervous System Neoplasm trials Research Report on Primary Central Nervous System Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Adavosertib, Irinotecan Hydrochloride - Central Nervous System Embryonal Tumor With Rhabdoid Features, Central Nervous System Embryonal Tumor, Not Otherwise Specified | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 76 | 2014-03-28 | 2023-09-26 |
Central Nervous System Neoplasms (1) · Medulloblastoma (1) · Neuroblastoma (1) · Neuroectodermal Tumors, Primitive (1) · Pinealoma (1) · Rhabdomyosarcoma (1)
Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Glioma (1) · Myosarcoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Muscle Tissue (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1)
Irinotecan (1) · adavosertib (1)
National Cancer Institute (NCI) (1)
Canada (1) · United States (1)
Kristina A Cole (1)
UM1CA097452 (1)